Parkside Financial Bank & Trust Has $157,000 Stock Position in Sanofi (NASDAQ:SNY)

Parkside Financial Bank & Trust increased its position in Sanofi (NASDAQ:SNY) by 12.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,250 shares of the company’s stock after purchasing an additional 348 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Sanofi were worth $157,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Synergy Asset Management LLC acquired a new position in shares of Sanofi during the 4th quarter worth about $25,000. McClarren Financial Advisors Inc. grew its position in shares of Sanofi by 952.6% during the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after buying an additional 543 shares during the period. Sunbelt Securities Inc. grew its position in shares of Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after buying an additional 313 shares during the period. Sierra Ocean LLC acquired a new position in shares of Sanofi during the 4th quarter worth about $44,000. Finally, Versant Capital Management Inc acquired a new position in shares of Sanofi during the 4th quarter worth about $54,000. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on SNY shares. Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research report on Thursday, January 30th. Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Finally, StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $60.00.

Sanofi Price Performance

Shares of SNY opened at $54.47 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. The stock has a 50 day simple moving average of $51.65 and a 200 day simple moving average of $52.60. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97. The firm has a market capitalization of $138.24 billion, a PE ratio of 21.88, a P/E/G ratio of 1.01 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. Sell-side analysts predict that Sanofi will post 4.36 EPS for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.